Back to News
Market Impact: 0.35
Medifast, Inc. Reports Third Quarter 2026 Revenue of $72.0 million
Source: Nasdaq
Corporate EarningsCompany Fundamentals
Medifast reported Q3 2026 revenue of $72.0 million, down 19.4% from $89.4 million in Q3 2025. The company attributed the decline primarily to a 47.7% decrease in active earning coaches; the supplied article text cuts off before giving the resulting coach count or further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
MED-0.70
More News
- From Wall Street to Silicon Valley, Anthropic IPO poised to have massive 'trickle-down effect'
- Microsoft offers buyouts to nearly 30% of workforce in ongoing AI shift
- Anthropic’s risk factors include the end of humanity, a feud with the Pentagon, and CEO Dario Amodei’s reputation
- Elon Musk warns more than 200 AI cloud companies face ‘guppy-level death’ as the AI boom runs into a debt crisis
- Why is PagSeguro Digital stock plummeting 30% today?
- China industrial profits post strongest growth in three months, rising 14.4%
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- AI for Investment Thesis Validation: A Claim-Ledger Method
- Capital Intensity as Gravity: The AI Trade Enters Its Industrial Era (Looking at Q3 2025 Earnings in Tech)